Reduced amide bond neurotensin 8-13 mimetics with potent in vivo activity

D. J. Wustrow, M. D. Davis, H. C. Akunne, A. E. Corbin, J. N. Wiley, L. D. Wise, T. G. Heffner

Research output: Contribution to journalArticlepeer-review

46 Scopus citations


Appropriately substituted 8-9 (ΨCH2NH) isosteres of neurotensin (NT) 8-13 have been found which are active as NT agonists in vitro and in vivo. SAR studies suggest that preventing amide bond hydrolysis at the 8-9 and 11-12 positions of NT(8-13) mimetics is important for producing compounds with potent activity in vivo. Other simplified replacements for the Arg-Arg portion of NT(8-13) are reported.

Original languageEnglish (US)
Pages (from-to)997-1002
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Issue number9
StatePublished - May 4 1995

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry


Dive into the research topics of 'Reduced amide bond neurotensin 8-13 mimetics with potent in vivo activity'. Together they form a unique fingerprint.

Cite this